ASKA Pharmaceutical Holdings CO., Ltd.JP:4886
| Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
---|
Operating revenue | - | 1,732 | 3,716 |
---|
Net sales | 56,607 | 60,461 | 62,843 |
---|
Operating expenses | 21,556 | 23,476 | 24,164 |
---|
Cost of sales | 30,255 | 31,876 | 32,178 |
---|
Operating profit (loss) | 4,795 | 5,108 | 6,500 |
---|
Gross profit (loss) | 26,351 | 28,584 | 30,664 |
---|
Interest income | - | - | 4 |
---|
Interest and dividend income | - | 1 | 1 |
---|
Dividend income | 258 | 338 | 330 |
---|
Other | 120 | 94 | 79 |
---|
Other | 120 | 94 | 79 |
---|
Non-operating income | 379 | 433 | 414 |
---|
Non-operating income | 379 | 433 | 414 |
---|
Selling, general and administrative expenses | 21,556 | 23,476 | 24,164 |
---|
Interest expenses | 56 | 50 | 40 |
---|
Share of loss of entities accounted for using equity method | - | 19 | 41 |
---|
Contribution of ESOP trust | - | 51 | - |
---|
Foreign exchange losses | 11 | 43 | 51 |
---|
Other | 38 | 57 | 98 |
---|
Loss on disposal of non-current assets | 43 | 52 | 13 |
---|
Non-operating expenses | 294 | 308 | 392 |
---|
Expenses of inactive non-current assets | 155 | 53 | 91 |
---|
Rental expenses on real estate | - | 6 | 55 |
---|
Contribution of ESOP trust | - | 51 | - |
---|
Other | 38 | 57 | 98 |
---|
Non-operating expenses | 294 | 308 | 392 |
---|
Operating profit (loss) | 4,795 | 5,108 | 6,500 |
---|
Ordinary profit (loss) | 4,880 | 5,232 | 6,522 |
---|
Interest income | - | - | 4 |
---|
Interest and dividend income | - | 1 | 1 |
---|
Dividend income | 258 | 338 | 330 |
---|
Other | 120 | 94 | 79 |
---|
Other | 120 | 94 | 79 |
---|
Non-operating income | 379 | 433 | 414 |
---|
Non-operating income | 379 | 433 | 414 |
---|
Interest expenses | 56 | 50 | 40 |
---|
Share of loss of entities accounted for using equity method | - | 19 | 41 |
---|
Contribution of ESOP trust | - | 51 | - |
---|
Foreign exchange losses | 11 | 43 | 51 |
---|
Other | 38 | 57 | 98 |
---|
Loss on disposal of non-current assets | 43 | 52 | 13 |
---|
Non-operating expenses | 294 | 308 | 392 |
---|
Expenses of inactive non-current assets | 155 | 53 | 91 |
---|
Rental expenses on real estate | - | 6 | 55 |
---|
Contribution of ESOP trust | - | 51 | - |
---|
Other | 38 | 57 | 98 |
---|
Non-operating expenses | 294 | 308 | 392 |
---|
Profit (loss) before income taxes | 6,163 | 5,357 | 9,862 |
---|
Ordinary profit (loss) | 4,880 | 5,232 | 6,522 |
---|
Income taxes - current | 983 | 1,108 | 3,514 |
---|
Gain on sale of investment securities | - | 124 | 3,340 |
---|
Extraordinary income | 9,683 | 124 | 3,340 |
---|
Income taxes - deferred | 890 | 10 | -1,197 |
---|
Profit (loss) before income taxes | 6,163 | 5,357 | 9,862 |
---|
Income taxes | 1,873 | 1,118 | 2,316 |
---|
Income taxes - current | 983 | 1,108 | 3,514 |
---|
Profit (loss) | 4,290 | 4,238 | 7,545 |
---|
Income taxes - deferred | 890 | 10 | -1,197 |
---|
Income taxes | 1,873 | 1,118 | 2,316 |
---|
Profit (loss) | 4,290 | 4,238 | 7,545 |
---|
Profit (loss) attributable to owners of parent | 4,290 | 4,238 | 7,545 |
---|